Suchen und filtern

Gefundene Studien

BATTALION Single-arm multicenter Phase II trial to investigate the efficacy of Botensilimab and Balstilimab in combination with gemcitabine/cisplatin for previously untreated patients with advanced or metastatic biliary tract cancer (CORAL-1, AIO HB XXXX) (BAlstilimab boTensilimab in the TreAtment of choLangIOcellular carcinoma) AIO-HEP-0123 · In Vorbereitung Studie anzeigen

QS-Harnblase 2023 Qualitätssicherungsinitiative zur Therapie des Harnblasenkarzinoms in Deutschland 2023 AIO-URO-0123/ass · In Vorbereitung Studie anzeigen

TEAM-D Transsektorale MTB-Plattform Deutschland AIO-TF-0323 · In Vorbereitung Studie anzeigen

ALTERED KRAS Wild-Type Pancreatic Cancer Data Register AIO-PAK/YMO_0223 · In Vorbereitung Studie anzeigen

DISCUSS Discontinuation of CDK4/6 inhibitors in patients with metastatic HR positive, HER2 negative breast cancer with durable disease control: A randomized phase II trial of the AIO working groups breast cancer and quality of life AIO-MAM-LQ-0223 · In Vorbereitung Studie anzeigen

SAGA A phase Ib/II single-arm, multicenter study of sacituzumab-govitecan, a TROP-2 targeting antibody linked with SN38, for patients with metastatic esophagogastric adenocarcinoma AIO-STO-0123/ass · In Vorbereitung Studie anzeigen

mFOLFIRINOX-SBA Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma AIO-KRK/YMO-0423 · In Vorbereitung Studie anzeigen

SMARAGD Registerplattform Ovarial-/Endometriumkarzinom Clinical Research Platform on Ovarian, Fallopian Tube, Primary Peritoneal, and Endometrial Cancer Treatment and Outcomes AIO-MAM-0123/ass · In Rekrutierung Studie anzeigen

onqo-Studie 2A Randomisiert-kontrollierte Studie zur Steigerung der krankheitsspezifischen Gesundheitskompetenz durch onqo AIO-DIG-0123/ass · In Rekrutierung Studie anzeigen

NeoColoPredict Neo-ColoPredict – transsectoral patient centered platform for neoadjuvant targeted treatment in early colon cancer AIO-KRK-0323 · In Vorbereitung Studie anzeigen